GLP NYSE Wholesale-Petroleum Bulk Stations & Terminals Financials FY2016βFY2025
Global Partners Lp had $18.6B of revenue in fiscal 2025, up 8.1% on the year before. Over five years, revenue changed +17.4% a year on average.
Last close Β· Oct 27, 2026
$47.70
+$2.09 (+4.58%) past year
Hi! I read Global Partners Lpβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+8.1%
Yes. Sales grew 8.1% last year.
Does it make a profit?
0.5%
A little. It keeps 0.5% of every sale as profit.
Does profit turn into cash?
1.0%
Partly. 1.0% of sales ends up as free cash.
How healthy are the accounts?
4 / 7
Mixed. It passes 4 of 7 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA summarises the numbers
Global Partners Lp had $18.6B of revenue in fiscal 2025, up 8.1% on the year before.
Over five years, revenue changed +17.4% a year on average.
Its operating margin was 1.3%, down 0.2Β pts: of every 100 in sales, about 1 is left after running the business.
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Loss periods are shown in red.
KIRA summarises the numbers
Global Partners Lp made $98.0M of net profit in fiscal 2025.
Net income
Net income
Diluted EPS
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
KIRA summarises the numbers
Free cash flow was $193M in fiscal 2025, 1.0% of revenue.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
KIRA summarises the numbers
Global Partners Lp returned $10.0M to shareholders in fiscal 2025, 5% of free cash flow.
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
KIRA summarises the numbers
In the last 12 months, insiders bought $9.9M and sold $1.4M of shares on the open market.
Bought, 12 months
$9.9M
1 insider
Sold, 12 months
$1.4M
1 insider
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.63 | $0.2M | Form 4 |
| Sep 17, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $51.08 | $0.3M | Form 4 |
| Sep 16, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $50.55 | $0.3M | Form 4 |
| Sep 15, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $50.89 | $0.3M | Form 4 |
| Sep 14, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $52.20 | $0.3M | Form 4 |
| Jun 18, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $42.81 | $0.2M | Form 4 |
| Jun 17, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $43.28 | $0.2M | Form 4 |
| Jun 15, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $46.69 | $0.2M | Form 4 |
| Jun 12, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $46.50 | $0.2M | Form 4 |
| Jun 10, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $50.17 | $0.3M | Form 4 |
| Jun 9, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.44 | $0.2M | Form 4 |
| Jun 8, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.29 | $0.2M | Form 4 |
| Jun 4, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.50 | $0.2M | Form 4 |
| Jun 3, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.42 | $0.2M | Form 4 |
| Jun 2, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.19 | $0.2M | Form 4 |
| Jun 1, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $48.41 | $0.2M | Form 4 |
| May 29, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $47.22 | $0.2M | Form 4 |
| May 28, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $48.35 | $0.2M | Form 4 |
| May 27, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $48.94 | $0.2M | Form 4 |
| May 26, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $48.92 | $0.2M | Form 4 |
| May 22, 2026 | Global GP LLCGeneral Partner | Bought | 4,184 | $50.05 | $0.2M | Form 4 |
| May 21, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $51.28 | $0.3M | Form 4 |
| May 20, 2026 | Global GP LLCGeneral Partner | Bought | 10,000 | $51.19 | $0.5M | Form 4 |
| May 19, 2026 | Global GP LLCGeneral Partner | Bought | 7,500 | $49.27 | $0.4M | Form 4 |
| May 18, 2026 | Global GP LLCGeneral Partner | Bought | 7,500 | $48.86 | $0.4M | Form 4 |
| May 15, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.17 | $0.2M | Form 4 |
| May 14, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $49.35 | $0.2M | Form 4 |
| May 13, 2026 | Global GP LLCGeneral Partner | Bought | 5,000 | $48.75 | $0.2M | Form 4 |
| Mar 25, 2026 | Mark RomaineChief Operating Officer | Sold | 2,065 | $44.80 | $0.1M | Form 4 |
| Mar 23, 2026 | Mark RomaineChief Operating Officer | Sold | 435 | $47.31 | $0.0M | Form 4 |
| Mar 20, 2026 | Mark RomaineChief Operating Officer | Sold | 2,020 | $48.19 | $0.1M | Form 4 |
| Mar 19, 2026 | Mark RomaineChief Operating Officer | Sold | 3,245 | $48.10 | $0.2M | Form 4 |
| Mar 18, 2026 | Mark RomaineChief Operating Officer | Sold | 4,735 | $47.76 | $0.2M | Form 4 |
| Mar 17, 2026 | Mark RomaineChief Operating Officer | Sold | 7,500 | $47.39 | $0.4M | Form 4 |
| Mar 16, 2026 | Mark RomaineChief Operating Officer | Sold | 3,376 | $47.00 | $0.2M | Form 4 |
| Mar 13, 2026 | Mark RomaineChief Operating Officer | Sold | 900 | $47.50 | $0.0M | Form 4 |
| Mar 12, 2026 | Mark RomaineChief Operating Officer | Sold | 1,148 | $47.56 | $0.1M | Form 4 |
| Mar 11, 2026 | Mark RomaineChief Operating Officer | Sold | 1,649 | $48.03 | $0.1M | Form 4 |
| Mar 10, 2026 | Mark RomaineChief Operating Officer | Sold | 252 | $48.50 | $0.0M | Form 4 |
| Mar 9, 2026 | Mark RomaineChief Operating Officer | Sold | 2,500 | $48.00 | $0.1M | Form 4 |
| Dec 23, 2025 | Global GP LLCGeneral Partner | Bought | 1,080 | $43.02 | $0.0M | Form 4 |
| Dec 22, 2025 | Global GP LLCGeneral Partner | Bought | 1,250 | $42.98 | $0.1M | Form 4 |
| Dec 19, 2025 | Global GP LLCGeneral Partner | Bought | 2,000 | $42.66 | $0.1M | Form 4 |
| Dec 18, 2025 | Global GP LLCGeneral Partner | Bought | 2,500 | $42.64 | $0.1M | Form 4 |
| Dec 17, 2025 | Global GP LLCGeneral Partner | Bought | 2,156 | $42.02 | $0.1M | Form 4 |
| Dec 16, 2025 | Global GP LLCGeneral Partner | Bought | 1,836 | $42.35 | $0.1M | Form 4 |
| Dec 15, 2025 | Global GP LLCGeneral Partner | Bought | 1,463 | $43.43 | $0.1M | Form 4 |
| Dec 11, 2025 | Global GP LLCGeneral Partner | Bought | 2,000 | $44.16 | $0.1M | Form 4 |
| Dec 8, 2025 | Global GP LLCGeneral Partner | Bought | 2,467 | $44.84 | $0.1M | Form 4 |
| Dec 5, 2025 | Global GP LLCGeneral Partner | Bought | 1,450 | $45.48 | $0.1M | Form 4 |
| Dec 4, 2025 | Global GP LLCGeneral Partner | Bought | 5,000 | $45.21 | $0.2M | Form 4 |
| Dec 3, 2025 | Global GP LLCGeneral Partner | Bought | 4,947 | $44.64 | $0.2M | Form 4 |
| Dec 2, 2025 | Global GP LLCGeneral Partner | Bought | 3,809 | $43.35 | $0.2M | Form 4 |
| Dec 1, 2025 | Global GP LLCGeneral Partner | Bought | 1,794 | $43.97 | $0.1M | Form 4 |
| Nov 26, 2025 | Global GP LLCGeneral Partner | Bought | 1,701 | $44.10 | $0.1M | Form 4 |
| Nov 25, 2025 | Global GP LLCGeneral Partner | Bought | 2,228 | $42.88 | $0.1M | Form 4 |
| Nov 24, 2025 | Global GP LLCGeneral Partner | Bought | 3,965 | $42.05 | $0.2M | Form 4 |
| Nov 21, 2025 | Global GP LLCGeneral Partner | Bought | 4,005 | $42.96 | $0.2M | Form 4 |
| Nov 20, 2025 | Global GP LLCGeneral Partner | Bought | 3,066 | $42.96 | $0.1M | Form 4 |
| Nov 19, 2025 | Global GP LLCGeneral Partner | Bought | 2,500 | $42.56 | $0.1M | Form 4 |
| Nov 18, 2025 | Global GP LLCGeneral Partner | Bought | 2,241 | $42.24 | $0.1M | Form 4 |
| Nov 14, 2025 | Global GP LLCGeneral Partner | Bought | 2,091 | $43.95 | $0.1M | Form 4 |
| Nov 13, 2025 | Global GP LLCGeneral Partner | Bought | 5,000 | $42.05 | $0.2M | Form 4 |
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Global Partners Lp can carry it.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $10.8M | $4.0M | $19.6M | $8.2M | $12.2M |
| Current ratio | 1.3x | 1.2x | 1.1x | 1.2x | 1.1x |
| Quick ratio | 0.7x | 0.6x | 0.7x | 0.6x | 0.6x |
| Total assets | $2.8B | $3.2B | $3.4B | $3.8B | $3.9B |
| Total liabilities | $2.3B | $2.4B | $2.6B | $3.1B | $3.2B |
| Net debt (β = net cash) | β | β | β | β | β |
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Return on capital, equity and assets (annual)
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
KIRA summarises the numbers
Global Partners Lp passes 4 of 7 financial health tests (Piotroski F-score).
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 6 / 7 | 3 / 7 | 6 / 7 | 3 / 7 | 6 / 7 | 4 / 7 | 4 / 7 | 4 / 7 |
| Accruals ratio | β3.1% | β11.9% | β2.7% | β2.2% | β7.9% | 0.4% | β3.9% | β10.9% | 2.2% | β4.9% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $8.2B | $8.9B | $12.7B | $13.1B | $8.3B | $13.2B | $18.9B | $16.5B | $17.2B | $18.6B |
| Gross profit | $546M | $583M | $650M | $663M | $721M | $719M | $1.1B | $974M | $1.1B | $1.1B |
| Operating income | β$152M | $120M | $197M | $139M | $192M | $142M | $460M | $244M | $251M | $235M |
| Pretax income | β$239M | $33.6M | $108M | $36.3M | $102M | $62.1M | $379M | $161M | $115M | $99.0M |
| Income tax | $0.1M | β$23.6M | $5.6M | $1.1M | β$0.1M | $1.3M | $16.8M | $8.1M | $4.6M | $1.1M |
| Net income | β$199M | $58.8M | $104M | $35.9M | $102M | $60.8M | $362M | $153M | $110M | $98.0M |
| Diluted EPS | β$5.91 | $1.74 | $2.95 | $0.81 | $2.74 | β | β | β | β | β |
| Diluted shares | 0.03B | 0.03B | β | β | β | β | β | β | β | β |
| Cash flow | ||||||||||
| Cash from operations | β$120M | $348M | $169M | $94.4M | $313M | $50.2M | $480M | $512M | $31.6M | $285M |
| Capital expenditure | $71.3M | $49.9M | $69.2M | $82.9M | $76.3M | $102M | $107M | $88.8M | $103M | $91.5M |
| Free cash flow | β$191M | $299M | $99.7M | $11.5M | $236M | β$51.5M | $373M | $424M | β$71.7M | $193M |
| Stock-based compensation | $4.1M | $2.8M | $2.7M | $2.0M | $1.1M | $0.7M | $2.7M | $10.6M | $15.5M | $13.4M |
| Acquisitions | β | $38.5M | $172M | β | β | $18.0M | $256M | $1.5M | β | β |
| Share buybacks | β | β | β | β | $0.3M | $3.8M | $2.9M | $3.5M | $14.2M | $10.0M |
| Dividends and buybacks | β | β | β | β | $0.3M | $3.8M | $2.9M | $3.5M | $14.2M | $10.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $10.0M | $14.9M | $8.1M | $12.0M | $9.7M | $10.8M | $4.0M | $19.6M | $8.2M | $12.2M |
| Current assets | $1.1B | $878M | $875M | $1.0B | $781M | $1.1B | $1.2B | $1.1B | $1.2B | $1.2B |
| Current liabilities | $799M | $669M | $583M | $754M | $498M | $840M | $971M | $983M | $1.0B | $1.1B |
| Inventory | $522M | $351M | $386M | $450M | $384M | $510M | $567M | $397M | $594M | $549M |
| Property and equipment, net | $1.1B | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B | $1.5B | $1.7B | $1.7B |
| Goodwill | $295M | $312M | $327M | $324M | $324M | $328M | $428M | $429M | $422M | $422M |
| Intangible assets | $65.0M | $56.5M | $58.5M | $46.8M | $35.9M | $26.0M | $26.9M | $20.7M | $18.7M | $13.4M |
| Total assets | $2.6B | $2.3B | $2.4B | $2.8B | $2.5B | $2.8B | $3.2B | $3.4B | $3.8B | $3.9B |
| Total liabilities | $2.2B | $1.9B | $1.9B | $2.3B | $2.0B | $2.3B | $2.4B | $2.6B | $3.1B | $3.2B |
| Margins | ||||||||||
| Gross margin | 6.6% | 6.5% | 5.1% | 5.1% | 8.7% | 5.4% | 5.8% | 5.9% | 6.2% | 5.7% |
| Operating margin | β1.8% | 1.3% | 1.6% | 1.1% | 2.3% | 1.1% | 2.4% | 1.5% | 1.5% | 1.3% |
| Net margin | β2.4% | 0.7% | 0.8% | 0.3% | 1.2% | 0.5% | 1.9% | 0.9% | 0.6% | 0.5% |
| FCF margin | β2.3% | 3.3% | 0.8% | 0.1% | 2.8% | β0.4% | 2.0% | 2.6% | β0.4% | 1.0% |
| Returns | ||||||||||
| Return on capital employed | β8.6% | 7.3% | 10.7% | 6.8% | 9.4% | 7.1% | 21.0% | 9.9% | 9.0% | 8.5% |
| Return on assets | β7.8% | 2.4% | 4.4% | 1.4% | 3.8% | 2.3% | 12.1% | 4.6% | 3.1% | 2.6% |
| Growth | ||||||||||
| Revenue growth | β | 8.3% | 42.1% | 3.2% | β36.4% | 59.2% | 42.5% | β12.6% | 4.1% | 8.1% |
| Net income growth | β | β | 76.9% | β65.5% | 185.0% | β40.5% | 495.8% | β57.9% | β27.7% | β11.2% |
| EPS growth | β | β | 69.5% | β72.5% | 238.3% | β | β | β | β | β |
| FCF growth | β | β | β66.6% | β88.4% | 1,947.1% | β121.8% | β | 13.5% | β116.9% | β |
| Share count change | β | 0.3% | β | β | β | β | β | β | β | β |
| Financial health | ||||||||||
| Current ratio | 1.3x | 1.3x | 1.5x | 1.3x | 1.6x | 1.3x | 1.2x | 1.1x | 1.2x | 1.1x |
| Quick ratio | 0.7x | 0.8x | 0.8x | 0.7x | 0.8x | 0.7x | 0.6x | 0.7x | 0.6x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.9% | 0.6% | 0.5% | 0.6% | 0.9% | 0.8% | 0.6% | 0.5% | 0.6% | 0.5% |
| Stock comp / revenue | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% |
| Payouts / FCF | β | β | β | β | 0.1% | β | 0.8% | 0.8% | β | 5.2% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 6.0 | 3.0 | 6.0 | 3.0 | 6.0 | 4.0 | 4.0 | 4.0 |
| Accruals ratio | β3.1% | β11.9% | β2.7% | β2.2% | β7.9% | 0.4% | β3.9% | β10.9% | 2.2% | β4.9% |
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
Source: SEC EDGAR XBRL filings (CIK 0001323468). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
